share_log

424B5: Prospectus

424B5: Prospectus

424B5:募資說明書
美股SEC公告 ·  01/06 20:03

Moomoo AI 已提取核心訊息

Aclarion, Inc. has announced a direct offering of 3,380,276 shares of common stock at $0.142 per share, raising gross proceeds of approximately $480,000. The offering is expected to close on or about January 6, 2025.The company intends to use the net proceeds to fund market development, clinical evidence, product development, quality initiatives, and general administrative support. Dawson James Securities, Inc. is acting as the exclusive placement agent for the offering.Aclarion is currently not in compliance with Nasdaq's minimum bid price and stockholders' equity requirements. The company has until April 7, 2025 to regain compliance with the bid price requirement and until January 31, 2025 for the stockholders' equity requirement. Aclarion is evaluating options to regain compliance and maintain its Nasdaq listing.
Aclarion, Inc. has announced a direct offering of 3,380,276 shares of common stock at $0.142 per share, raising gross proceeds of approximately $480,000. The offering is expected to close on or about January 6, 2025.The company intends to use the net proceeds to fund market development, clinical evidence, product development, quality initiatives, and general administrative support. Dawson James Securities, Inc. is acting as the exclusive placement agent for the offering.Aclarion is currently not in compliance with Nasdaq's minimum bid price and stockholders' equity requirements. The company has until April 7, 2025 to regain compliance with the bid price requirement and until January 31, 2025 for the stockholders' equity requirement. Aclarion is evaluating options to regain compliance and maintain its Nasdaq listing.
Aclarion公司已宣佈直接發行3,380,276股普通股,價格爲每股0.142美元,籌集總收益約48萬美元。此發行預計將在2025年1月6日左右完成。該公司打算將淨收益用於市場開發、臨牀證據、產品開發、質量計劃和一般行政支持。Dawson James Securities公司作爲此次發行的獨家安置代理。 Aclarion目前不符合納斯達克的最低買盤價格和股東權益要求。該公司必須在2025年4月7日之前恢復對買盤價格要求的合規性,並在2025年1月31日之前恢復股東權益要求的合規性。Aclarion正在評估期權以恢復合規性並維持其納斯達克上市。
Aclarion公司已宣佈直接發行3,380,276股普通股,價格爲每股0.142美元,籌集總收益約48萬美元。此發行預計將在2025年1月6日左右完成。該公司打算將淨收益用於市場開發、臨牀證據、產品開發、質量計劃和一般行政支持。Dawson James Securities公司作爲此次發行的獨家安置代理。 Aclarion目前不符合納斯達克的最低買盤價格和股東權益要求。該公司必須在2025年4月7日之前恢復對買盤價格要求的合規性,並在2025年1月31日之前恢復股東權益要求的合規性。Aclarion正在評估期權以恢復合規性並維持其納斯達克上市。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息